Web Stats Provided By Google Analytics

Wednesday, November 29, 2017

CymaBay Therapeutics (CBAY) Rating Reiterated by Leerink Swann

... Wace North America L.P. bought a new position in CymaBay Therapeutics in the 2nd quarter valued at $242,000. Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns 50,210 ...
http://ift.tt/2BldqO6

No comments:

Post a Comment

Popular Ardsley Roundup Posts